Prognostic Epigenetics

· Translational Epigenetics āļŦāļ™āļąāļ‡āļŠāļ·āļ­āđ€āļĨāđˆāļĄāļ—āļĩāđˆ 15 · Academic Press
eBook
442
āļŦāļ™āđ‰āļē
āļĄāļĩāļŠāļīāļ—āļ˜āļīāđŒ
āļ„āļ°āđāļ™āļ™āđāļĨāļ°āļĢāļĩāļ§āļīāļ§āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāļ•āļĢāļ§āļˆāļŠāļ­āļšāļĒāļ·āļ™āļĒāļąāļ™  āļ”āļđāļ‚āđ‰āļ­āļĄāļđāļĨāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āđ€āļāļĩāđˆāļĒāļ§āļāļąāļš eBook āđ€āļĨāđˆāļĄāļ™āļĩāđ‰

This volume provides comprehensive information on how mapping an individual's epigenome can be medically relevant and holds the potential to improve preventive medicine and precision therapeutics at an early-stage (prior to disease onset). In order to advance clinical adoption of the recently developed epigenetic approaches, it is necessary for translational scientists, clinicians, and students to gain a better understanding about epigenetic mechanisms that are associated with a particular disorder; and to be able to effectively identify biomarkers that can be applied in drug development and for better diagnosis and prognosis of diseases. Prognostic Epigenetics is the most-inclusive volume to-date specifically dedicated to epigenetic markers that have been developed for prognosis of diseases, recent advances in this field, the clinical implementation of this research, and the future outlook. - Compiles all known information on prognostic epigenetics and its role in preventive medicine and drug discovery - Covers the basic functionality of epigenetic mechanisms involved in early disease prognosis and diagnosis, and provides tools for the identification and development of these biomarkers for a wide range of diseases - Enables clinicians, researchers, and pharmacologists to improve preventive medicine and precision therapeutics throughout a person's lifetime - Features chapter contributions from leading international researchers

āđ€āļāļĩāđˆāļĒāļ§āļāļąāļšāļœāļđāđ‰āđāļ•āđˆāļ‡

Dr. Shilpy Sharma, PhD, is an Assistant Professor at the Department of Biotechnology, Savitribai Phule Pune University (Formerly University of Pune) in Pune, Maharashtra, India. She has served as a Post-Doctoral Fellow in the Department of Pharmacology at University of Michigan and as a Post-Doctoral Fellow at the Department of Surgery, University of Chicago Medical Center. Dr. Sharma’s research focuses on identification of prognostic biomarkers for complex disorders including cancer, diabetes, and asthma; and infectious diseases.

āđƒāļŦāđ‰āļ„āļ°āđāļ™āļ™ eBook āļ™āļĩāđ‰

āđāļŠāļ”āļ‡āļ„āļ§āļēāļĄāđ€āļŦāđ‡āļ™āļ‚āļ­āļ‡āļ„āļļāļ“āđƒāļŦāđ‰āđ€āļĢāļēāļĢāļąāļšāļĢāļđāđ‰

āļ‚āđ‰āļ­āļĄāļđāļĨāđƒāļ™āļāļēāļĢāļ­āđˆāļēāļ™

āļŠāļĄāļēāļĢāđŒāļ—āđ‚āļŸāļ™āđāļĨāļ°āđāļ—āđ‡āļšāđ€āļĨāđ‡āļ•
āļ•āļīāļ”āļ•āļąāđ‰āļ‡āđāļ­āļ› Google Play Books āļŠāļģāļŦāļĢāļąāļš Android āđāļĨāļ° iPad/iPhone āđāļ­āļ›āļˆāļ°āļ‹āļīāļ‡āļ„āđŒāđ‚āļ”āļĒāļ­āļąāļ•āđ‚āļ™āļĄāļąāļ•āļīāļāļąāļšāļšāļąāļāļŠāļĩāļ‚āļ­āļ‡āļ„āļļāļ“ āđāļĨāļ°āļŠāđˆāļ§āļĒāđƒāļŦāđ‰āļ„āļļāļ“āļ­āđˆāļēāļ™āđāļšāļšāļ­āļ­āļ™āđ„āļĨāļ™āđŒāļŦāļĢāļ·āļ­āļ­āļ­āļŸāđ„āļĨāļ™āđŒāđ„āļ”āđ‰āļ—āļļāļāļ—āļĩāđˆ
āđāļĨāđ‡āļ›āļ—āđ‡āļ­āļ›āđāļĨāļ°āļ„āļ­āļĄāļžāļīāļ§āđ€āļ•āļ­āļĢāđŒ
āļ„āļļāļ“āļŸāļąāļ‡āļŦāļ™āļąāļ‡āļŠāļ·āļ­āđ€āļŠāļĩāļĒāļ‡āļ—āļĩāđˆāļ‹āļ·āđ‰āļ­āļˆāļēāļ Google Play āđ‚āļ”āļĒāđƒāļŠāđ‰āđ€āļ§āđ‡āļšāđ€āļšāļĢāļēāļ§āđŒāđ€āļ‹āļ­āļĢāđŒāđƒāļ™āļ„āļ­āļĄāļžāļīāļ§āđ€āļ•āļ­āļĢāđŒāđ„āļ”āđ‰
eReader āđāļĨāļ°āļ­āļļāļ›āļāļĢāļ“āđŒāļ­āļ·āđˆāļ™āđ†
āļŦāļēāļāļ•āđ‰āļ­āļ‡āļāļēāļĢāļ­āđˆāļēāļ™āļšāļ™āļ­āļļāļ›āļāļĢāļ“āđŒ e-ink āđ€āļŠāđˆāļ™ Kobo eReader āļ„āļļāļ“āļˆāļ°āļ•āđ‰āļ­āļ‡āļ”āļēāļ§āļ™āđŒāđ‚āļŦāļĨāļ”āđāļĨāļ°āđ‚āļ­āļ™āđ„āļŸāļĨāđŒāđ„āļ›āļĒāļąāļ‡āļ­āļļāļ›āļāļĢāļ“āđŒāļ‚āļ­āļ‡āļ„āļļāļ“ āđ‚āļ›āļĢāļ”āļ—āļģāļ•āļēāļĄāļ§āļīāļ˜āļĩāļāļēāļĢāļ­āļĒāđˆāļēāļ‡āļĨāļ°āđ€āļ­āļĩāļĒāļ”āđƒāļ™āļĻāļđāļ™āļĒāđŒāļŠāđˆāļ§āļĒāđ€āļŦāļĨāļ·āļ­āđ€āļžāļ·āđˆāļ­āđ‚āļ­āļ™āđ„āļŸāļĨāđŒāđ„āļ›āļĒāļąāļ‡ eReader āļ—āļĩāđˆāļĢāļ­āļ‡āļĢāļąāļš